<ѻýҕl>Borderline Pulmonary Hypertension Tied to Mortality Riskѻýҕl> Small increases in pressure might signal left heart failure, not early PAH Oct 25, 2017
<ѻýҕl>Supplements Affect NT-ProBNP; Cord Stem Cells; ED Exit Sans Stress Testѻýҕl> Cardiovascular Daily wraps up the top cardiology news of the week Sep 29, 2017
<ѻýҕl>Entresto Boosts Sex in HF; Venom Antidote to Xa Drugs; Guilty Plea for FH Vaguenessѻýҕl> Recent developments of interest in cardiovascular medicine Sep 25, 2017
<ѻýҕl>HF Monitor Trips on PA Injury in Postmarket Surveillanceѻýҕl> Reintervention or device recalibration often needed after PA injury Sep 18, 2017
<ѻýҕl>TTR Cardiomyopathy Easily Detected By Biceps Bunchingѻýҕl> Biceps tendon rupture may be a clue to HF cause Sep 12, 2017
<ѻýҕl>ESC: Merck REVEALS a Slightly Positive CETP Inhibitor Trialѻýҕl> A CETP inhibitor scores after 3 strikes for the class Aug 29, 2017
<ѻýҕl>Inflammation, Secondary Prevention, Diet in Spotlight at ESCѻýҕl> CANTOS, COMPASS, PURE will headline the world's largest cardiology meeting Aug 24, 2017
<ѻýҕl>Guidance Issued on PET Imaging in Diagnosing Cardiac Sarcoidosisѻýҕl> ASNC, SNMMI release recommendations for difficult diagnostic challenge Aug 19, 2017
<ѻýҕl>Studies Stop Short of Quelling TAVR Durability Fearsѻýҕl> Structural valve deterioration observed in 3.9% over 5 years May 20, 2017
<ѻýҕl>Does Longer TAVR Time Make Stroke More Likely?ѻýҕl> SURTAVI neuro substudy bolsters comparability between TAVR, SAVR May 19, 2017
<ѻýҕl>Lotus TAVR Device Again Trips Up on Pacemaker Rateѻýҕl> Otherwise, efficacy superior overall against CoreValve in REPRISE III trial May 17, 2017
<ѻýҕl>As Hospital TAVR Volume Goes Up, Readmits Go Downѻýҕl> Is it time for TAVR regionalization? May 14, 2017
<ѻýҕl>Lower BP Targeted in New Heart Failure Guidelinesѻýҕl> ACC/AHA/HFSA recommend adjusted SPRINT target of May 02, 2017
<ѻýҕl>CardioBrief: Serious Questions Raised About Validity Of International Trialsѻýҕl> TOPCAT analysis is the 'smoking gun' for trouble from 'offshoring' trials Apr 26, 2017
<ѻýҕl>Best (Musical) Beats for CPR Training (CNN)ѻýҕl> Synchrony with CPR components essential Mar 21, 2017
<ѻýҕl>Dosing Crucial for Digoxin, Warfarin Safetyѻýҕl> Digoxin unsafe at high levels regardless of heart failure Mar 21, 2017
<ѻýҕl>SURTAVI: TAVR Matches Surgery in Lowest-Risk Cohortѻýҕl> But reinterventions, parvalvular regurgitation, and pacemaker implants mar a supposed victory Mar 17, 2017
<ѻýҕl>Everyday Exposure to EM Fields Can Disrupt Pacemakersѻýҕl> Lower sensitivity and bipolar sensing recommended Feb 27, 2017
<ѻýҕl>Wise Buy? Left Ventricular Assist Devicesѻýҕl> Getting better and cheaper, but 'nobody wears pink ribbons for heart failure' Feb 21, 2017
<ѻýҕl>Subclavian TAVR Safe When Femoral Access Is Riskyѻýҕl> Trial analysis shows similar morbidity, mortality Jan 24, 2017
<ѻýҕl>SAVR Beats Expectations in Intermediate Risk Trialѻýҕl> Lower mortality than surgical risk score predicted in PARTNER 2A Jan 24, 2017
<ѻýҕl>Novartis Pulls Out of Controversial Entresto Contestѻýҕl> Cardiologists named to review panel had quit Dec 19, 2016
<ѻýҕl>CMS to Offer Billing Code for Heart Failure Specialistsѻýҕl> Should eliminate denials for appearance of double-billing Dec 02, 2016
<ѻýҕl>Trial: No Benefit for High-Dose Diuretic in Acute HFѻýҕl> But phase II results might not be the final word Nov 17, 2016
<ѻýҕl>AHA: No Pump Thrombosis With Next-Gen LVAD?ѻýҕl> Better outcomes in HeartMate 3 trial hinged on fewer malfunctions Nov 16, 2016
<ѻýҕl>AHA: Real World TAVR Is All About Patient Selectionѻýҕl> Intermediate risk is a moving target Nov 15, 2016
<ѻýҕl>AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilatorѻýҕl> Investigational drug ularitide had no effect on mortality or clinical outcomes Nov 13, 2016
<ѻýҕl>TCT: TAVR Holds Up Pretty Well Over Timeѻýҕl> Also, 2-year data confirm lasting improvements in QoL Nov 02, 2016
<ѻýҕl>TCT: Embolic Protection Flops for TAVRѻýҕl> New brain lesions or clinical strokes unaffected in SENTINEL trial Nov 01, 2016
<ѻýҕl>CardioBrief: Impella No Better Than IABP in Cardiogenic Shockѻýҕl> Underpowered IMPRESS trial shows no mortality benefit Oct 30, 2016
<ѻýҕl>HFSA: Clinical Benefits Tied To Lung Monitoring Persistѻýҕl> HF rehospitalization, deaths remain reduced up to 4.5 years Sep 21, 2016
<ѻýҕl>Cardiac Myosin Activator Shows Promise for LV Functionѻýҕl> 'More hands pulling on the rope' Sep 21, 2016
<ѻýҕl>HFSA: Treat to NT-proBNP Target Flops in Trialѻýҕl> Outcomes no better with treatment aimed at 30% reduction Sep 20, 2016
<ѻýҕl>HFSA: Did LAP Monitoring Cut HF Rehospitalizations?ѻýҕl> LAPTOP-HF investigators tried to make sense of terminated study Sep 19, 2016
<ѻýҕl>ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?ѻýҕl> No clinical difference in small trial, but preclinical measures suggestive Aug 29, 2016
<ѻýҕl>ESC: No Mortality Benefit With ICD in Nonischemic HFѻýҕl> Eleven fewer deaths over 5 years Aug 28, 2016
<ѻýҕl>Stores' Security Systems Can Mess With Cardiac Devicesѻýҕl> ICD, pacemaker hiccups seen near anti-shoplifting monitors in lab study Jun 10, 2016
<ѻýҕl>Compression Stockings; Stroke Prevention; Stents and Medsѻýҕl> Cardiovascular Daily wraps up the top cardiology news of the week Jun 03, 2016
<ѻýҕl>Survival Rates Good With VAD for Complicated Acute MIѻýҕl> Despite being sicker to start, outcomes on par with other VAD patients Apr 18, 2016
<ѻýҕl>Podcast: 10th Anniversary for HealthNewsReview.orgѻýҕl> Gary Schwitzer reflects on high points, low points, lessons learned Apr 14, 2016